vimarsana.com

ஸ்க் வைத்திருத்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SK Holdings acquires French pharmaceutical company Yposkesi

SK Holdings acquires French pharmaceutical company Yposkesi Photo by: SK/YouTube Related Stories SK Holdings revealed its acquisition of a French drug-maker called Yposkesi this week. The third-largest conglomerate in South Korea made the purchase in its bid to strengthen its competitive power in the global market’s biotech sector. Moreover, SK has acquired French drug manufacturer Yposkesi to expand into the rapidly growing contract manufacturing organization (CMO) business, the newly renamed holding company of SK Group said Wednesday. SK completed the acquisition The Korea Times reported that SK acquired 70% percent shares, and this includes management rights in the French company. The acquisition came four months after the South Korean company said it is in talks to purchase Yposkesi.

Adnoc, Korea s GS Eye Hydrogen Opportunities

Adnoc, Korea s GS Eye Hydrogen Opportunities Mar 5, 2021 7:10:am Summary by: Joe Murphy Abu Dhabi s state-owned Adnoc has teamed up with South Korea s GS Energy to explore opportunities in developing value chains for blue hydrogen and carrier fuels such as . Posted in:

Korea s SK Group Plans $16 5bn Investment in Hydrogen

Korea s SK Plans $16.5bn Investment in Hydrogen South Korea’s SK Holding, part of SK Group, will invest won 18.5 trillion ($16.5bn) over the next five years to develop a hydrogen production-distribution-consumption ecosystem, it said on March 2.   As part of the plan, it will invest won 500bn to develop a hydrogen-based fuel cell power plant by 2023 in Incheon, with a capacity of 30,000 metric tons (mt)/year of liquid hydrogen. This facility will use hydrogen recycled from the petrochemicals manufactured at the nearby plant.   SK Holdings will also invest won 5.3 trillion to develop a facility to produce 250,000 mt/year of hydrogen from LNG.  

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.